In California, Antitrust Claims Over Patent Settlements Survive
SAN FRANCISCO — Allegations of antitrust violations by a putative class in connection with patent settlement agreements between the makers of combination antiretroviral therapy (cART) drugs for the treatment of HIV...To view the full article, register now.
Already a subscriber? Click here to view full article